𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Evaluation of lactate and alanine as metabolic biomarkers of prostate cancer using 1H HR-MAS spectroscopy of biopsy tissues

✍ Scribed by May-Britt Tessem; Mark G. Swanson; Kayvan R. Keshari; Mark J. Albers; David Joun; Z. Laura Tabatabai; Jeffry P. Simko; Katsuto Shinohara; Sarah J. Nelson; Daniel B. Vigneron; Ingrid S. Gribbestad; John Kurhanewicz

Publisher
John Wiley and Sons
Year
2008
Tongue
English
Weight
494 KB
Volume
60
Category
Article
ISSN
0740-3194

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

The goal of this study was to investigate the use of lactate and alanine as metabolic biomarkers of prostate cancer using ^1^H high‐resolution magic angle spinning (HR‐MAS) spectroscopy of snap‐frozen transrectal ultrasound (TRUS)‐guided prostate biopsy tissues. A long‐echo‐time rotor‐synchronized Carr‐Purcell‐Meiboom‐Gill (CPMG) sequence including an electronic reference to access in vivo concentrations (ERETIC) standard was used to determine the concentrations of lactate and alanine in 82 benign and 16 malignant biopsies (mean 26.5% ± 17.2% of core). Low concentrations of lactate (0.61 ± 0.28 mmol/kg) and alanine (0.14 ± 0.06 mmol/kg) were observed in benign prostate biopsies, and there was no significant difference between benign predominantly glandular (N = 54) and stromal (N = 28) biopsies between patients with (N = 38) and without (N = 44) a positive clinical biopsy. In biopsies containing prostate cancer there was a highly significant (P < 0.0001) increase in lactate (1.59 ± 0.61 mmol/kg) and alanine (0.26 ± 0.07 mmol/kg), and minimal overlap with lactate concentrations in benign biopsies. This study demonstrates for the first time very low concentrations of lactate and alanine in benign prostate biopsy tissues. The significant increase in the concentration of both lactate and alanine in biopsy tissue containing as little as 5% cancer could be exploited in hyperpolarized ^13^C spectroscopic imaging (SI) studies of prostate cancer patients. Magn Reson Med 60:510–516, 2008. © 2008 Wiley‐Liss, Inc.

📜 SIMILAR VOLUMES

Evaluation of the ERETIC method as an im
Evaluation of the ERETIC method as an improved quantitative reference for 1H HR-MAS spectroscopy of prostate tissue
✍ Mark J. Albers; Thomas N. Butler; Iman Rahwa; Nguyen Bao; Kayvan R. Keshari; Mar 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 285 KB

## Abstract The Electronic REference To access In vivo Concentrations (ERETIC) method was applied to ^1^H HR‐MAS spectroscopy. The accuracy, precision, and stability of ERETIC as a quantitative reference were evaluated in solution and human prostate tissue samples. For comparison, the reliability o

Methods for metabolic evaluation of pros
Methods for metabolic evaluation of prostate cancer cells using proton and 13C HR-MAS spectroscopy and [3-13C] pyruvate as a metabolic substrate
✍ Yakir S. Levin; Mark J. Albers; Thomas N. Butler; Daniel Spielman; Donna M. Peeh 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 359 KB

## Abstract Prostate cancer has been shown to undergo unique metabolic changes associated with neoplastic transformation, with associated changes in citrate, alanine, and lactate concentrations. ^13^C high resolution‐magic angle spinning (HR‐MAS) spectroscopy provides an opportunity to simultaneous